NimoGel™ Shows Promise at Preventing Delayed Complications of Sudden Brain Injury in a Preclinical Study
Contrary to popular belief, New Jersey has many hidden treasures and now Edge Therapeutics, a Newark, New Jersey based biopharmaceutical company has made tremendous headway in their quest for a cure for debilitating and potentially fatal brain injuries.